The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C04 | Peripheral vasodilators | |
| 3 | C04A | Peripheral vasodilators | |
| 4 | C04AX | Other peripheral vasodilators |
| Code | Title | |
|---|---|---|
| C04AX01 | Cyclandelate | |
| C04AX02 | Phenoxybenzamine | |
| C04AX07 | Vincamine | |
| C04AX10 | Moxisylyte | |
| C04AX11 | Bencyclane | |
| C04AX17 | Vinburnine | |
| C04AX19 | Suloctidil | |
| C04AX20 | Buflomedil | |
| C04AX21 | Naftidrofuryl | |
| C04AX23 | Butalamine | |
| C04AX24 | Visnadine | |
| C04AX26 | Cetiedil | |
| C04AX27 | Cinepazide | |
| C04AX28 | Ifenprodil | |
| C04AX30 | Azapetine | |
| C04AX32 | Fasudil | |
| C04AX33 |
| Active Ingredient | Description | |
|---|---|---|
| Bencyclane |
|
|
| Buflomedil |
|
|
| Clazosentan |
|
|
| Fasudil |
|
|
| Ifenprodil |
|
|
| Naftidrofuryl |
Naftidrofuryl oxalate is a powerful vasodilator agent with an antagonist effect on 5-HT2 receptors of the smooth muscle cells. The vasodilator effect, which occurs in both the cerebral and peripheral circulation, is probably the main action. It is claimed that this action protects cells against the metabolic effects of ischaemia. |
|
| Phenoxybenzamine |
Phenoxybenzamine is a non competitive long acting α-adrenergic receptor antagonist. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CLARANTIN Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| OPILON Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PHENOXYBENZAMINE Capsules | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
